Atlas Trials

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Clinical trial NCT01365494 · COMPLETED

Trial details

NCT number
NCT01365494
Sponsor
Novartis Vaccines
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rabies
Start date
2011-07-01
Primary completion
2011-11-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.